Acute Myeloid Leukemia (AML) exhibits significant heterogeneity in clinical outcomes, yet current prognostic stratification systems based on genetic alterations alone cannot fully capture this complexity.
This study aimed to develop an integrated epigenetic-based classification system and evaluate its prognostic value.
